The Adipokine Network in Rheumatic Joint Diseases
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Rheumatic diseases encompass a diverse group of chronic disorders that commonly affect musculoskeletal structures. Osteoarthritis (OA) and rheumatoid arthritis (RA) are the two most common, leading to considerable functional limitations and irreversible disability when patients are unsuccessfully treated. Although the specific causes of many rheumatic conditions remain unknown, it is generally accepted that immune mechanisms and/or uncontrolled inflammatory responses are involved in their etiology and symptomatology. In this regard, the bidirectional communication between neuroendocrine and immune system has been demonstrated to provide a homeostatic network that is involved in several pathological conditions. Adipokines represent a wide variety of bioactive, immune and inflammatory mediators mainly released by adipocytes that act as signal molecules in the neuroendocrine-immune interactions. Adipokines can also be synthesized by synoviocytes, osteoclasts, osteoblasts, chondrocytes and inflammatory cells in the joint microenvironment, showing potent modulatory properties on different effector cells in OA and RA pathogenesis. Effects of adiponectin, leptin, resistin and visfatin on local and systemic inflammation are broadly described. However, more recently, other adipokines, such as progranulin, chemerin, lipocalin-2, vaspin, omentin-1 and nesfatin, have been recognized to display immunomodulatory actions in rheumatic diseases. This review highlights the latest relevant findings on the role of the adipokine network in the pathophysiology of OA and RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Glyn-Jones, S., Palmer, A. J. R., Agricola, R., Price, A. J., Vincent, T. L., Weinans, H., & Carr, A. J. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60802-3 · Cited by 3,151
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
Sellam, J., & Berenbaum, F. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.159 · Cited by 1,500
Inflammation in osteoarthritis
Goldring, M. B., & Otero, M. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328349c2b1 · Cited by 1,462
Immunopathogenesis of Rheumatoid Arthritis
Firestein, G. S., & McInnes, I. B. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.006 · Cited by 1,301
Goldring, M. B., & Goldring, S. R. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.21258 · Cited by 1,179
Obesity and Knee Osteoarthritis: The Framingham Study
Felson, D. T., Anderson, J. J., Naimark, A., Walker, A. M., & Meenan, R. F. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-1-18 · Cited by 1,080
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
Revollo, J. R., Körner, A., Mills, K. F., Satoh, A., Wang, T., Garten, A., Dasgupta, B., Sasaki, Y., Wolberger, C., Townsend, R. R., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.003 · Cited by 911
Wittamer, V., Franssen, J.-D., Vulcano, M., Mirjolet, J.-F., Le Poul, E., Migeotte, I., Brézillon, S., Tyldesley, R., Blanpain, C., Detheux, M., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030382 · Cited by 888
Tang, W., Lu, Y., Tian, Q.-Y., Zhang, Y., Guo, F.-J., Liu, G.-Y., Syed, N. M., Lai, Y., Lin, E. A., Kong, L., et al. (2011) · Science · doi:10.1126/science.1199214 · Cited by 761
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490 · cited 1×
“Hence, the increased expression of PGRN at local sites of inflammation is suggested to be linked to its ability to initiate immune activation by recruiting fibroblasts, macrophages and neutrophils at the site of inflammation [194].”
BackgroundThe sympathetic nervous response in inflammation
Pongratz, G., & Straub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0504-2 · Cited by 427
Synthetic chemerin-derived peptides suppress inflammation through ChemR23
Cash, J. L., Hart, R., Russ, A., Dixon, J. P. C., Colledge, W. H., Doran, J., Hendrick, A. G., Carlton, M. B. L., & Greaves, D. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071601 · Cited by 372 · cited 1×
“Anti-inflammatory properties have been described by mouse chem156S, homologous to human chem157S, on macrophage [210] and in a LPS-induced acute lung injury model [211].”
BackgroundProcaccini, C., Jirillo, E., & Matarese, G. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.012 · Cited by 299 · cited 1×
“Most immune cells express LEPR at their surface, which has also been described for chondrocytes, SF and osteoblasts [87,88].”
BackgroundThe infrapatellar fat pad of patients with osteoarthritis has an inflammatory phenotype
Klein-Wieringa, I. R., Kloppenburg, M., Bastiaansen-Jenniskens, Y. M., Yusuf, E., Kwekkeboom, J. C., El-Bannoudi, H., Nelissen, R. G. H. H., Zuurmond, A., Stojanovic-Susulic, V, Van Osch, G. J. V. M., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140046 · Cited by 289 · cited 1×
“Moreover, an inflammatory profile in the infrapatellar fat pad (IPFP) of OA patients has been described [19].”
BackgroundShen, F., Ruddy, M. J., Plamondon, P., & Gaffen, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904490 · Cited by 268
Adiponectin promotes muscle regeneration through binding to T-cadherin
Tanaka, Y., Kita, S., Nishizawa, H., Fukuda, S., Fujishima, Y., Obata, Y., Nagao, H., Masuda, S., Nakamura, Y., Shimizu, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37115-3 · Cited by 103
Martel-Pelletier, J., Raynauld, J.-P., Dorais, M., Abram, F., & Pelletier, J.-P. (2016) · Rheumatology · doi:10.1093/rheumatology/kev408 · Cited by 68
Sato, K., Shirai, R., Yamaguchi, M., Yamashita, T., Shibata, K., Okano, T., Mori, Y., Matsuyama, T.-A., Ishibashi-Ueda, H., Hirano, T., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061732 · Cited by 36 · cited 1×
“In the context of human coronary atheromatous plaques, the pro-inflammatory phenotype of human macrophages was suppressed by vaspin [244].”
Background
Cited by
Recinella, L., Orlando, G., Ferrante, C., Chiavaroli, A., Brunetti, L., & Leone, S. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.578966 · Cited by 261
Leptin in osteoarthritis and rheumatoid arthritis: Player or bystander?
Ait Eldjoudi, D., Cordero Barreal, A., Gonzalez-Rodríguez, M., Ruiz-Fernández, C., Farrag, Y., Farrag, M., Lago, F., Capuozzo, M., Gonzalez-Gay, M. A., Mera Varela, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052859 · Cited by 72
“Rheumatic disorders include many different forms of arthritis, such as osteoarthritis (OA) and rheumatoid arthritis (RA), that lead to pain, swollen joints, and progressive damage to articular cartilage [1].”
BackgroundRole of adipose tissues in osteoarthritis
Zapata-Linares, N., Eymard, F., Berenbaum, F., & Houard, X. (2021) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000763 · Cited by 54
“Vaspin In vitro Possible anticatabolic effect in human cartilage [16]”
BackgroundRole of Adipokines in Sarcopenia
Lu, W., Feng, W., Lai, J., Yuan, D., Xiao, W., & Li, Y. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002255 · Cited by 34
The Influence of Adipokines on Radiographic Damage in Inflammatory Rheumatic Diseases
Toussirot, E. (2023) · Biomedicines · doi:10.3390/biomedicines11020536 · Cited by 12
“Visfatin regulates insulin secretion and has insulin-like effects [7,8].”
Background
Metadata
- Authors
- Carrión, M., Frommer, K. W., Pérez-García, S., Müller-Ladner, U., Gomariz, R. P., & Neumann, E.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-08-22
- Volume
- 20
- Issue
- 17
- Pages
- 4091
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2969558314
- Cited by
- 101
- References
- 19
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.